Posted inDiabetes & Endocrinology Gastroenterology news Time-Restricted Eating as a Promising Approach for Metabolic Dysfunction-Associated Steatotic Liver Disease: Evidence from a Randomized Controlled Trial Posted by By MedXY 10/28/2025No Comments Highlight Time-restricted eating (TRE) significantly reduces hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) over 16 weeks. TRE shows similar efficacy to traditional calorie restriction (CR) regarding weight loss, body composition, and metabolic parameters. No serious adverse events were reported, suggesting TRE is a safe and practical dietary strategy for MASLD management. Study Background MedXY View All Posts Post navigation Previous Post Evaluating Surrogate Endpoints in Advanced Biliary Tract Cancer: Progression-Free Survival Outperforms Response Rates as a Predictor of Overall SurvivalNext PostPlant-Based Foods and Their Impact on Metabolic Health and Liver Function in Adults with MASLD and Comorbidities: A Systematic Review
